JP2006524565A5 - - Google Patents

Download PDF

Info

Publication number
JP2006524565A5
JP2006524565A5 JP2006505309A JP2006505309A JP2006524565A5 JP 2006524565 A5 JP2006524565 A5 JP 2006524565A5 JP 2006505309 A JP2006505309 A JP 2006505309A JP 2006505309 A JP2006505309 A JP 2006505309A JP 2006524565 A5 JP2006524565 A5 JP 2006524565A5
Authority
JP
Japan
Prior art keywords
particles
organic
compound
inorganic
liquid medium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006505309A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006524565A (ja
JP5207432B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2004/004506 external-priority patent/WO2004096405A1/en
Publication of JP2006524565A publication Critical patent/JP2006524565A/ja
Publication of JP2006524565A5 publication Critical patent/JP2006524565A5/ja
Application granted granted Critical
Publication of JP5207432B2 publication Critical patent/JP5207432B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2006505309A 2003-04-29 2004-04-28 アンチ溶媒凝固プロセス Expired - Fee Related JP5207432B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US46676103P 2003-04-29 2003-04-29
US60/466,761 2003-04-29
PCT/EP2004/004506 WO2004096405A1 (en) 2003-04-29 2004-04-28 Antisolvent solidification process

Publications (3)

Publication Number Publication Date
JP2006524565A JP2006524565A (ja) 2006-11-02
JP2006524565A5 true JP2006524565A5 (https=) 2007-07-05
JP5207432B2 JP5207432B2 (ja) 2013-06-12

Family

ID=33418418

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006505309A Expired - Fee Related JP5207432B2 (ja) 2003-04-29 2004-04-28 アンチ溶媒凝固プロセス

Country Status (22)

Country Link
US (4) US20060182808A1 (https=)
EP (1) EP1620193B1 (https=)
JP (1) JP5207432B2 (https=)
KR (1) KR20060006949A (https=)
CN (1) CN100434133C (https=)
AR (1) AR044140A1 (https=)
AT (1) ATE406946T1 (https=)
AU (1) AU2004234057A1 (https=)
BR (1) BRPI0409860A (https=)
CA (1) CA2523883C (https=)
CL (1) CL2004000912A1 (https=)
DE (1) DE602004016311D1 (https=)
ES (1) ES2312996T3 (https=)
IL (1) IL171613A (https=)
MX (1) MXPA05011626A (https=)
MY (1) MY141189A (https=)
NO (1) NO20055607D0 (https=)
NZ (1) NZ543772A (https=)
RU (1) RU2339364C2 (https=)
TW (1) TW200500095A (https=)
WO (1) WO2004096405A1 (https=)
ZA (1) ZA200509597B (https=)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006272438B2 (en) * 2005-07-15 2011-08-04 Map Pharmaceuticals, Inc. Method of particle formation
AU2006269961B2 (en) * 2005-07-15 2012-07-19 Map Pharmaceuticals, Inc. Multiple active pharmaceutical ingredients combined in discrete inhalation particles and formulations thereof
US7942990B2 (en) 2006-12-18 2011-05-17 Daicel Chemical Industries, Ltd. Hybrid inflator
ES2381892T3 (es) * 2007-01-22 2012-06-01 Cargill, Incorporated Procedimiento para producir composiciones de rebaudiósido A purificado que utiliza la cristalización disolvente/antidisolvente
GB0705159D0 (en) * 2007-03-19 2007-04-25 Prosonix Ltd Process for making crystals
GB0711680D0 (en) * 2007-06-18 2007-07-25 Prosonix Ltd Process
FI120527B (fi) * 2007-06-18 2009-11-30 Crisolteq Oy Talteenottomenetelmä
US20100291221A1 (en) * 2009-05-15 2010-11-18 Robert Owen Cook Method of administering dose-sparing amounts of formoterol fumarate-budesonide combination particles by inhalation
TWI466709B (zh) * 2011-07-20 2015-01-01 Nat Univ Chung Hsing From the original berry Wolfberry a liquid - liquid freezing method for separation of high purity theaflavins palmitate Maize
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
BR112014012444B1 (pt) 2011-11-23 2021-12-14 Therapeuticsmd, Inc Composição farmacêutica compreendendo estradiol solubilizado, progesterona e um agente de solubilização, bem como usos desta para tratar um sintoma relacionado à menopausa em uma mulher
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9452930B2 (en) * 2013-11-04 2016-09-27 New Jersey Institute Of Technology System and method for continuous polymer coating of particles
RU2016143081A (ru) 2014-05-22 2018-06-26 Терапьютиксмд, Инк. Натуральные комбинированные гормонозаместительные составы и терапии
PT108368B (pt) 2015-03-31 2018-11-05 Hovione Farm S A Produção contínua de partículas
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
CN106853295A (zh) * 2015-12-09 2017-06-16 北大方正集团有限公司 一种基于膜分散的结晶方法
US9931349B2 (en) 2016-04-01 2018-04-03 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
US10881123B2 (en) * 2017-10-27 2021-01-05 Frito-Lay North America, Inc. Crystal morphology for sodium reduction
US11857930B2 (en) * 2018-06-14 2024-01-02 Jgc Corporation Crystallization apparatus and crystallization method
CN112969466B (zh) * 2018-12-28 2024-12-24 四川科伦药物研究院有限公司 制备黄体酮颗粒物的方法、所得黄体酮颗粒物及其注射剂
CN111234431A (zh) * 2020-03-31 2020-06-05 宁夏颐星新材料科技有限公司 一种消泡型聚乙烯醇粉末的生产工艺
GB202004824D0 (en) 2020-04-01 2020-05-13 Naturbeads Ltd Biopolymer particle preparation
GB202011836D0 (en) 2020-07-30 2020-09-16 Micropore Tech Limited Crystallisation methods
CN115777906A (zh) * 2021-09-10 2023-03-14 吉林大学 氯化钠纳微米粒子及其制备方法和应用
AU2023408533A1 (en) 2022-12-22 2025-08-07 Nanomi B.V. Process for preparing stable nanoparticle and composition thereof
CN117942426B (zh) * 2024-03-22 2024-05-31 四川大学 一种具有取向孔道结构的多级多孔材料及其制备方法和应用

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2716453B1 (fr) * 1994-02-22 1996-03-29 Rhone Poulenc Agrochimie Procédé de sulfinylation de composés hétérocycliques.
US4089843A (en) * 1976-09-20 1978-05-16 The Upjohn Company Precipitating polymers in powder form
US4826689A (en) * 1984-05-21 1989-05-02 University Of Rochester Method for making uniformly sized particles from water-insoluble organic compounds
US4783484A (en) * 1984-10-05 1988-11-08 University Of Rochester Particulate composition and use thereof as antimicrobial agent
JPH0672528B2 (ja) * 1985-07-16 1994-09-14 三信工業株式会社 船舶のエンジン
RU2026670C1 (ru) * 1988-10-05 1995-01-20 Дзе Апджон Компани Способ получения тонкодисперсного твердого фармацевтического вещества
US5269926A (en) * 1991-09-09 1993-12-14 Wisconsin Alumni Research Foundation Supported microporous ceramic membranes
FR2658498B1 (fr) * 1990-02-19 1992-05-15 Atochem Particules de chlorure de magnesium a structure tronc conique, composante catalytique supportee sur ces particules, polyolefines obtenues a partir de cette composante catalytique, procedes de fabrication de ces produits.
JP2555475B2 (ja) * 1990-10-16 1996-11-20 工業技術院長 無機質微小球体の製造方法
JP2816597B2 (ja) * 1990-11-28 1998-10-27 富士写真フイルム株式会社 溶液の均一混合装置および弾性体多孔膜
IE71202B1 (en) * 1990-12-17 1997-02-12 Akzo Nv Progestagen-only contraceptive
WO1993000156A1 (fr) * 1991-06-29 1993-01-07 Miyazaki-Ken Emulsions monodispersees simples et doubles et procede de production
AU671811B2 (en) * 1991-12-18 1996-09-12 Warner-Lambert Company A process for the preparation of a solid dispersion
DK95093D0 (da) * 1993-08-20 1993-08-20 Novo Nordisk As Farmaceutisk formulering indeholdende et hormon
EP0868942A1 (en) * 1993-11-08 1998-10-07 The Gillette Company Method of forming particles using a supercritical fluid and aerogel particles formed thereby
JP3492787B2 (ja) * 1994-04-15 2004-02-03 信越化学工業株式会社 固形製剤のコーティング用水性エマルジョンの濃縮方法
US6387399B1 (en) * 1994-12-02 2002-05-14 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Microencapsulated bioactive agents and method of making
SE9501384D0 (sv) * 1995-04-13 1995-04-13 Astra Ab Process for the preparation of respirable particles
US5876480A (en) * 1996-02-20 1999-03-02 The United States Of America As Represented By The Secretary Of The Navy Synthesis of unagglomerated metal nano-particles at membrane interfaces
GB9610955D0 (en) * 1996-05-24 1996-07-31 Hercules Inc Sizing composition
IL123984A (en) * 1997-04-22 2004-09-27 Akzo Nobel Nv Pharmacological dosage units containing tibolone and carrier pharmacy are acceptable
US5879715A (en) * 1997-09-02 1999-03-09 Ceramem Corporation Process and system for production of inorganic nanoparticles
KR20010042566A (ko) * 1998-04-09 2001-05-25 프리돌린 클라우스너, 롤란드 비. 보레르 압축된 기체 및 계면활성제중에 용해시킴으로써, 크기가마이크론 이하인 입자를 제조하는 방법
SE9801287D0 (sv) * 1998-04-14 1998-04-14 Astra Ab Incorporation of active substances in carrier matrixes
US6113795A (en) * 1998-11-17 2000-09-05 The University Of Kansas Process and apparatus for size selective separation of micro- and nano-particles
US7374779B2 (en) * 1999-02-26 2008-05-20 Lipocine, Inc. Pharmaceutical formulations and systems for improved absorption and multistage release of active agents
IN191236B (https=) * 1999-05-25 2003-10-11 Ranbaxy Lab Ltd
US6780507B2 (en) * 2000-02-09 2004-08-24 Analytical Research Systems, Inc. Hydrocapsules and method of preparation thereof
US6623761B2 (en) * 2000-12-22 2003-09-23 Hassan Emadeldin M. Method of making nanoparticles of substantially water insoluble materials
GB0102075D0 (en) * 2001-01-26 2001-03-14 Astrazeneca Ab Process
CA2458889C (en) * 2001-08-29 2011-06-21 Dow Global Technologies Inc. A process for preparing crystalline drug particles by means of precipitation
MXPA04003321A (es) * 2001-10-10 2004-07-23 Boehringer Ingelheim Pharma Procesado de polvo con fluidos gaseosos presurizados.
US6890592B2 (en) * 2002-03-13 2005-05-10 Appleton Papers Inc. Uniform microcapsules
US6966990B2 (en) * 2002-10-11 2005-11-22 Ferro Corporation Composite particles and method for preparing

Similar Documents

Publication Publication Date Title
JP2006524565A5 (https=)
CA2523883A1 (en) Antisolvent solidification process
DE69105106T2 (de) Im wasser schnell suspendierbare pharmazeutische zusammensetzung.
EP2822539B1 (en) Nanocrystalline solid dispersion compositions
JP2009502487A5 (https=)
Kalpana et al. Solid Dispersion: Approaches, Technology involved, Unmet need & Challenges.
Paradkar et al. Preparation and evaluation of ibuprofen beads by melt solidification technique
WO1994008561A1 (fr) Procede de dislocation d'un etat cristallin
UA127892C2 (uk) Спосіб одержання частинок ізоксазоліну великого розміру
CN109071461A (zh) 制备5-氨基-2,3-二氢噻嗪-1,4-二酮结晶体的方法
JPH09503522A (ja) Ｓ（＋）−イブプロフェン粒子の製造方法
Newa et al. Preparation and evaluation of immediate release ibuprofen solid dispersions using polyethylene glycol 4000
EP1165049A2 (en) Agglomerates by crystallisation
JP3578993B2 (ja) コア／シェル構造を有する凝集体の製造方法
CN101874784B (zh) 析出结晶药物缓控释微球粒及其制备方法
Fodor-Kardos et al. Preparation of protein loaded chitosan microparticles by combined precipitation and spherical agglomeration
CN1149824A (zh) 珠的制法以及含有熔点不确定活性成份的珠状物
JP2000504309A (ja) 医薬用顆粒
US20170304207A1 (en) Manufacture of a pharmaceutical product
Singh et al. Effects of the Eudragit and Drug coat on the release behaviour of poorly soluble drug by solid dispersion technique
KR100340215B1 (ko) β-ＨＭＸ의 재결정 방법
Patil et al. SOLID DISPERSION: AN EVOLUTIONARY PLAN FOR SOLUBILITY ENHANCEMENT OF POORLY WATER SOLUBLE DRUGS.
Muthukumar Chapter-6 Solid Dispersion
Yadav et al. solubility enhancement and bioavailability improvement strategies
CN112999224A (zh) 一种布洛芬载来那度胺复合颗粒及其制备方法